Channel One Style
SEE OTHER BRANDS

The latest news on culture, society and lifestyle

Channel One Style: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Channel One Style.

Press releases published on May 9, 2025

BDO Unibank, Inc. to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference May 15th

BDO Unibank, Inc. to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference May 15th

MANILA, Philippines, May 09, 2025 (GLOBE NEWSWIRE) -- BDO Unibank, Inc. (BDO, BDOUY) based in the Philippines, and focused on providing financial products and services, today announced that BDO Unibank, Inc. Executive Vice President, Luis S. Reyes will …

Best Sugar Baby Websites [2025] Top Sugar Daddy Sites for Sugar Babies And Sugar Daddies to Meet!

Best Sugar Baby Websites [2025] Top Sugar Daddy Sites for Sugar Babies And Sugar Daddies to Meet!

Las Vegas, Nevada, May 09, 2025 (GLOBE NEWSWIRE) -- Find the best sugar baby websites and top-rated sugar daddy sites trusted by millions of attractive sugar babies and affluent sugar daddies to connect safely, chat instantly, and meet on your terms. Las …

Renowned Neurosurgeon Dr. Mohana Rao (Dr. Rao) Chooses Guntur Over Global Metropolises, Revolutionizing Local Healthcare

Renowned Neurosurgeon Dr. Mohana Rao (Dr. Rao) Chooses Guntur Over Global Metropolises, Revolutionizing Local Healthcare

Dr. Mohana Rao Patibandla's Quiet Revolution in Neurosurgery GUNTUR, ANDHRA PRADESH, INDIA, May 9, 2025 /⁨EINPresswire.com⁩/ -- Renowned Neurosurgeon Dr. Rao Chooses Guntur Over Global Metropolises, Revolutionizing Local Healthcare Dr. Mohana Rao …

Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada

Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada

REYKJAVIK, Iceland, May 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the BofA Securities …

Esperion to Participate in H.C. Wainwright’s 3rd Annual BioConnect Investor Conference

Esperion to Participate in H.C. Wainwright’s 3rd Annual BioConnect Investor Conference

ANN ARBOR, Mich., May 09, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20, 2025, at 10 a.m. ET. The live webcast …

Fiverr to Present at Upcoming Conference

Fiverr to Present at Upcoming Conference

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Fiverr International Ltd, (NYSE: FVRR), the company that is changing how the world works together, today announced that Micha Kaufman, Founder and Chief Executive Officer, and Ofer Katz, President and Chief …

Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025

Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025

DURHAM, N.C., May 09, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results for the …

IMPROVLearning Expands Defensive Driving Courses to More New York Cities as Insurance Rates Continue to Climb

IMPROVLearning Expands Defensive Driving Courses to More New York Cities as Insurance Rates Continue to Climb

NEW YORK, NY, May 09, 2025 (GLOBE NEWSWIRE) -- IMPROVLearning, an industry leader in online driver education, today announced the further expansion of its New York state defensive driving program to include four additional cities. This timely expansion …

Troell Cosmetic Surgery & Facial Plastic Clinic Announce $500 Off Fat Transfer Breast Augmentation in Las Vegas

Troell Cosmetic Surgery & Facial Plastic Clinic Announce $500 Off Fat Transfer Breast Augmentation in Las Vegas

Las Vegas, NV, May 09, 2025 (GLOBE NEWSWIRE) -- Troell Cosmetic Surgery …

PyroGenesis Schedules First Quarter 2025 Financial Results and Business Update Conference Call

PyroGenesis Schedules First Quarter 2025 Financial Results and Business Update Conference Call

MONTREAL, May 09, 2025 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis”) (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a high-tech company that designs, develops, manufactures and commercializes advanced all-electric plasma processes …

Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting

Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting

ALPHARETTA, Ga., May 09, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS …

Aclaris Therapeutics to Participate in the HC Wainwright “HCW@Home” Series

Aclaris Therapeutics to Participate in the HC Wainwright “HCW@Home” Series

WAYNE, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that Aclaris’ Chief …

Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025

Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025

CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the …

Gogo Announces First Quarter 2025 Results

Gogo Announces First Quarter 2025 Results

Total Revenue of $230.3 million, up 121% Year-over-Year; First Quarter Service Revenue of $198.6 million, up 143% Year-over-Year Q1 Net Income of $12.0 million; Adjusted EBITDA(1) of $62.1 million Achieved PMA approval for FDX, Gogo Galileo's larger LEO …

Taboola to Participate in Upcoming Investor Conferences

Taboola to Participate in Upcoming Investor Conferences

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Taboola (Nasdaq: TBLA), a global leader in delivering performance at scale for advertisers, today announced that members of its management team will participate in the following investor conferences: Event: …

Best Men’s Clothing (2025): Charles Tyrwhitt Recognized as Top Menswear Brand by Expert Consumers

Best Men’s Clothing (2025): Charles Tyrwhitt Recognized as Top Menswear Brand by Expert Consumers

NEW YORK CITY, May 09, 2025 (GLOBE NEWSWIRE) -- Expert Consumers has named Charles Tyrwhitt one of the top menswear brands of the year, highlighting its dedication to clothing quality and craftsmanship. The recognition is part of Expert Consumers’ ongoing …

Hesai Group to Report First Quarter 2025 Financial Results on Monday, May 26, 2025

Hesai Group to Report First Quarter 2025 Financial Results on Monday, May 26, 2025

SHANGHAI, China, May 09, 2025 (GLOBE NEWSWIRE) -- Hesai Group (“Hesai,” “Hesai Technology” or the “Company”) (NASDAQ: HSAI), the global leader in three-dimensional light detection and ranging (lidar) solutions, today announced that it will report its first …

Akero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening of MASH at the EASL Congress 2025

Akero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening of MASH at the EASL Congress 2025

SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, presented …

Artax Biopharma presents Phase 2a results for oral Nck modulator AX-158 in late-breaking session at the Society for Investigative Dermatology 2025 Annual Meeting

Artax Biopharma presents Phase 2a results for oral Nck modulator AX-158 in late-breaking session at the Society for Investigative Dermatology 2025 Annual Meeting

First small molecule to modulate the fundamental mechanism of T cell activation underlying autoimmune pathology Statistically significant improvements in T cell and psoriasis-related biomarkers in line with PASI improvements in Phase 2a in patients with …

Rectify Pharma Presents Translational Data for Novel Positive Functional Modulator Demonstrating Improved Biliary and Liver Health at EASL 2025

Rectify Pharma Presents Translational Data for Novel Positive Functional Modulator Demonstrating Improved Biliary and Liver Health at EASL 2025

Oral dual-targeted ABCB4/BSEP positive functional modulator (PFM) improved cholestatic and cholangitis markers in orthogonal models of hepatobiliary disease Data reinforce the potential of this differentiated mechanism of action (MOA) to address the core …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service